| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |